Difference between revisions of "Team:TU Dresden/Project/Results"

Line 60: Line 60:
 
   <a href="https://2015.igem.org/Team:TU_Dresden/Project/Results#folding"></a>
 
   <a href="https://2015.igem.org/Team:TU_Dresden/Project/Results#folding"></a>
  
   <p style="line-height:1.8"></p>
+
  <h4 id="">Transformation experiments</h4>
 +
 
 +
   <p style="line-height:1.8">The plasmid encoding the soluble part of the Her2 fragment was designed as per bio-brick specifications and synthesized by IDT (Her2 codon) (figure 1). </p>
 +
 
 +
<figure align="center">
 +
<a href="https://static.igem.org/mediawiki/2015/a/a4/TU_Dresden_plasmid_her2_solublepart.png" title="View">
 +
  <IMG SRC="https://static.igem.org/mediawiki/2015/a/a4/TU_Dresden_plasmid_her2_solublepart.png" style="width: 40%;"/></a>
 +
<div style="font-size: 13px">
 +
  <caption>Figure 1 - pIDTSMART-KAN plasmid encoding the soluble part of the Her2 protein coding sequence. Synthesized by IDT, contains kanamycin resistance for selection.</caption>
 +
</div>
 +
</figure>
 +
 
 +
  <p style="line-height:1.8">Since the above plasmid is not an expression plasmid, the Her2 fragment had to be subcloned into another plasmid (pET28a), which is a common expression plasmid containing N/C-terminal Histidine tag. The Her2 fragment was amplified from the biobrick plasmid pIDTSMART-KAN using primers - subcl_fwd and subcl_rev (refer primer sequence) created with and additional restriction site NheI. The cloning was done by conventional method, digestion of both the Her2 amplified fragment and the pET28a vector with NotI and NheI restriction enzymes.</p>
 +
 
 +
 
 +
<figure align="center">
 +
<a href="https://static.igem.org/mediawiki/2015/b/b5/TU_Dresden_pET28a_plasmid_linearized.png" title="View">
 +
  <IMG SRC="https://static.igem.org/mediawiki/2015/b/b5/TU_Dresden_pET28a_plasmid_linearized.png" style="width: 40%;"/></a>
 +
<div style="font-size: 13px">
 +
  <caption>Figure 2 -  pET28a plasmid linearized with both NotI and NheI. We may not be able to see the cut fragment as it is few bp in length. The PCR fragment after cut with NotI and NheI was gel purified and hence no electrophoresis data is shown.</caption>
 +
</div>
 +
</figure>
  
  
Line 85: Line 106:
 
   <h4 id="">Interactions of HER2 and its affibody</h4>
 
   <h4 id="">Interactions of HER2 and its affibody</h4>
  
     <p style="line-height:1.8">After definition of the interfaciual atoms, electrostatic interactions in the interface can be defined and visualized as shown in figure 1.
+
     <p style="line-height:1.8">After definition of the interfaciual atoms, electrostatic interactions in the interface can be defined and visualized as shown in figure 2.
  
 
     <table border="1" style="margin-left: auto; margin-right: auto;">
 
     <table border="1" style="margin-left: auto; margin-right: auto;">

Revision as of 17:59, 16 September 2015


Results

Folding study of target protein

Transformation experiments

The plasmid encoding the soluble part of the Her2 fragment was designed as per bio-brick specifications and synthesized by IDT (Her2 codon) (figure 1).

Figure 1 - pIDTSMART-KAN plasmid encoding the soluble part of the Her2 protein coding sequence. Synthesized by IDT, contains kanamycin resistance for selection.

Since the above plasmid is not an expression plasmid, the Her2 fragment had to be subcloned into another plasmid (pET28a), which is a common expression plasmid containing N/C-terminal Histidine tag. The Her2 fragment was amplified from the biobrick plasmid pIDTSMART-KAN using primers - subcl_fwd and subcl_rev (refer primer sequence) created with and additional restriction site NheI. The cloning was done by conventional method, digestion of both the Her2 amplified fragment and the pET28a vector with NotI and NheI restriction enzymes.

Figure 2 - pET28a plasmid linearized with both NotI and NheI. We may not be able to see the cut fragment as it is few bp in length. The PCR fragment after cut with NotI and NheI was gel purified and hence no electrophoresis data is shown.

Structure analysis of our targets and their interactions

Structure check of HER2

The Ramachandran plot shows the phi-psi torsion angles for all residues in the structure (except those at the chain termini). Glycine residues are separately identified by triangles as these are not restricted to the regions of the plot appropriate to the other sidechain types.

The colouring/shading on the plot represents regions with different favorability: the darkest areas (here shown in red) correspond to the "core" regions representing the most favourable combinations of phi-psi values.

Ideally, one would hope to have over 90 % of the residues in these "core" regions. The percentage of residues in the "core" regions is one of the better guides to stereochemical quality.

Interactions of HER2 and its affibody

After definition of the interfaciual atoms, electrostatic interactions in the interface can be defined and visualized as shown in figure 2.

h-bonds hbonds hbonds
Figure 1 - Electrostatic interactions of HER2 and its affibody ZHER2 shown as dashed yellow lines. Labels indicate the respective atom distances.

A total number of 9 hydrogen bonds were identified between HER2 and its affibody. Those are listed below with their respective distances.

Conservation study of HER2

In order to get an impression about possible variabilities of the HER2 structure a conservation study of HER2 was performed using 11 structures from different organisms (figure 2). The multiple sequence alignment which is required for the calculation can be seen here. Looking at the binding interface of HER2 and its affibody, we can state that the regions where both get into contact are rather conserved.

Figure 2 - HER2 conservation - calculated using 11 HER2 structures from different organisms.

Negative results:

Performing the rather automatic analysis of HER2 conservation by using all available HER2 structures gives a very large amount of structures to compare with.

This results in large alignment gaps and in an overall relatively low conservation without larger shade differences except for single amino acid (the whole Amino Acid Conservation Scores can be found here and the first lines of the color coded alignment can be seen here). Therefore the the sample is too large for a nice visualization and also the database structures might be biased.

In case of the affibody a conservation analysis could not be performed since it is an artificially engineered molecule. Therefore, in order to nevertheless get an impression about possible variabilities of the affibody structure an analysis of its cristallographic B-factors was performed.

Visualization of the B-factor for the affibody ZHER2

In crystallography the B-factor, also called temperature factor or "Debye-Waller factor", describes the displacement of an atom from its mean position in a crystal structure. The displacement may be the result of temperature-dependent atomic vibrations or static disorder in a crystal lattice. Static disorder means that some regions of the molecule may adopt different conformations in different copies of the molecule, each molecule's conformation being relatively stable. In the case of our affibody static disorder is not so probable, since it is a very small protein, designed to adopt a stable conformation.

Reflecting the disorder of an atom, the B-factor is therefore an indicator for flexibility caused by thermal motion.

As depicted in the following pictures the affibody has low B-factor values, meaning that it stays in a stable position without any larger fluctuations (indicated by the blue color). Only at the ends of the molecule a slight increase of the B-factor can be stated. This is normal and due to thermal motion, since the atoms have less interaction partners there, which can hold them on place. This stable position of the affibody suggests a high binding affinity at this position.

B-factor1 B-factor4 B-factor6
Affibody ZHER2 surface coloured by b-factor Affibody ZHER2 structure coloured by b-factor Affibody ZHER2 structure coloured by b-factor
Figure 3 - The affinity matured 3-helix affibody ZHER2 binding to HER2 (PDB-ID: 3MZW). Affibody coloured by B-factor (colour gradient: blue - green - red), HER2 in grey.

Video

The following video shows the structure of the extracellular regions of HER2 with the affinity matured 3-helix affibody ZHER2 (PDB-ID: 3MZW) and focuses on their interaction, whereas hydrogen bonds are represented as dashed yellow lines and then the complete interacting interface is represented as surface, colored by atom type (N-blue, O-red).

Investigation of P3 threshold for E. coli resistance

Transformation of E. coli with the construct

To study the resistance that is build up by E. coli as response to P3 production, we constructed a plasmid that carries P3. The expression can be controlled by the inducible

Figure 4 - Final construct of pLac, P3, RBS and CFP. The induction of the promoter leads to the expression of P3 and the coexpression of CFP as a reporter.

The plasmid was transformed into the F+, Δ(lacZ) E. coli strain after its construction. The F+ gives the M13 phages the possibility to infect the bacteria. Because of the lacZ deficiency the alpha-complementation can be carried out by the phages and the cells can be used for lacZ/blue-white screening. To have a very simple check for the functionality of the construct, we placed the induced cells on a UV table. A clear blue fluorescence could be seen, but not distinguished from the auto-fluorescence of the LB medium. Thus we performed the more sophisticated analysis of the induced cells with a 3D scan over a wide range of excitation and emission wavelengths.

To get hands on the grade of resistance we used the blue-white screening that gives a ratio of infected (blue) to uninfected cells (white). Before we conducted the measurement in the reactor we tested if the blue-white screening works as assumed in simple reaction tubes (figure 5) and on LB plates (figure 6).

Figure 5 - Left: ER2738 cells induced with X-Gal but without M13mp18. Right: Production of blue dye as a response to the infection with M13mp18. The phage performs the alpha-complementation of the damaged Β-galactosidase. The enzyme can then convert X-Gal into the blue indigo dye.
Figure 6 - The plate was covered with top-agar which contained infected and uninfected cells. A continuous bacteria carpet developed and turned blue at the spots where infected cells grew. The bigger blue spots arose from condensate drops that allowed the phages to spread after the top agar was deposited.

The first cultures in the minimal medium showed a growth in the expected range until an OD600 of roughly 0.4. After transferring the culture into a second flask, the growth decreased, leading to a final OD600 around 1. After transferring parts of the culture into a new flask with fresh medium no growth could be detected, even though the prolin which the strain needed was added. The experiments were repeated several times with the result that the strain was missing more nutrition which was provided by the initial cells coming from the LB-plates. We decided to move the more intense medium missing studies to a later date and try to perform a proof of concept with our strain. Therefore yeast extract was added to the medium and growth could be observed. It was also decided to add the yeast extract to the medium reservoir of the continuous cultivation.

CFP expression

Two samples (one of an induced culture (2 mM IPTG) and a IPTG free culture) were measured using a fluorescence spectrometer. Both samples had an OD of 1. A fluorescence signal peak resulting from a CFP expression was expected in a range from 435-440 nm (excitation) and from 470-476 nm (emission) in the induced sample. In contrast, a lower fluorescence signal in this wavelength region was expected for the IPTG free sample due to a lower concentration of IPTG. The measured 3D fluorescence spectra are shown in figure 7. As expected, the IPTG free showed a fluorescence signal, which was around 50 to 100 units lower than in the induced culture. This indicates a lower CFP expression in the IPTG free sample. However, the CFP expression in the induced sample was too low to see a clear peak in the fluorescence spectrum. This might be a result of the co-expression of IPTG after the P3 expression. Furthermore, the cell culture could have entered the static phase, which could result in a nutrition limitation and a lower CFP expression.

Analysis of the plasmid stability

The plasmid stability was analyzed with the samples for the phage infection. The stability of the plasmid showed itself around 90 % over the whole cultivation the missing 10 % are most likely a result of problems with the transferring of the cultures with the stamp. Therefore the high plasmid stability in the system can be assumed. The antibiotics are degraded by the chloramphenicol acetyltransferase. Thus it is likely that most of the antibiotics are being deactivated during the cultivation leaving the assumption that the plasmid might be stable even without an antibiotic in the medium. To ensure the stability more experiments will be performed with an antibiotic free medium. The minimal medium that will be used also helps to ensure a low infection rate.

Analysis of the phage infection

As a next step the phages were added to the lagoon and cultivated for 2 hours. A sample was taken and plated on the X-Gal plates as a result around 25 % of the colonies showed a color change as a result of the infection. Over the next time the IPTG concentration was increased step-wise. All samples except the one with the 3 mM IPTG concentration showed some infected colonies which leads to the first assumption that, only after a concentration of 3 mM of IPTG, the induction is high enough to stop the infection. But, as all of the induced samples showed a low infection rate, it might be possible that the sample only contained a small amount of phages. Due to a lack of time, only a small part of the planned continuous cultivations could be performed. Therefore, further cultivation is required to determine the phage infection. Furthermore, it should be considered to analyze the expression level achieved with the different IPTG concentrations.

Figure 7 - 3D fluorescence spectra of an induced E. coli culture sample (left: 2 mM IPTG) and a E. coli culture sample without IPTG (right). Both samples had an OD of 1.

Conversion of BACTH into an iGEM standard and analysis of function

Set up of flow system

Continuous stirred-tank cultivation

The continuous cultivation was performed after the initial cultivation. The experience with the minimal media lead to the decision to use the minimal media with yeast extract. The initial batch cultivation was performed overnight and had a final OD600 of 0.43. The next step the continuous cultivation was started. After roughly 9 hours and the resulting 2 volume changes, the OD600 stabilized around 0.18 and reached the continuous state of the cultivation. Then, the plasmid stability and phage infection could be analyzed.